financetom
Business
financetom
/
Business
/
COVID-19 claims in FY22 could be double of FY21, says ICICI Prudential CFO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
COVID-19 claims in FY22 could be double of FY21, says ICICI Prudential CFO
May 27, 2021 6:17 AM

The COVID-19 claims in FY22 could be double of what they were in FY21, said Satyan Jambunathan, CFO of ICICI Prudential Life Insurance, on Thursday.

According to industry sources, the COVID-19 claims to rise sharply for life insurance companies.

Speaking in an interview with CNBC-TV18, Jambunathan said, "Claims could be more likely twice of what it was last year. But with vaccination picking up, the number of infection is going down. Therefore, our expectation would be more around 1.5-2 times of last year's on COVID claims. Of course, we have to closely watch how it emerges and, if necessary, we will increase provisions as we go through the year."

On business, he said, "We added a lot of distribution during the second half of last year, we added some new bank partnerships, we added over 20,000 new agents through our agency force and we expect annuities and retirement products to see good growth."

For the entire interview, watch the video

(Edited by : Priyanka Rathi)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hologic Insider Sold Shares Worth $1,241,296, According to a Recent SEC Filing
Hologic Insider Sold Shares Worth $1,241,296, According to a Recent SEC Filing
Mar 15, 2024
04:16 PM EDT, 03/15/2024 (MT Newswires) -- Scott T Garrett, Director, on March 14, 2024, sold 16,441 shares in Hologic ( HOLX ) for $1,241,296. Following the Form 4 filing with the SEC, Garrett has control over a total of 48,611 shares of the company, with 48,611 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/859737/000112760224010261/xslF345X03/form4.xml Price: 75.92, Change: +0.01, Percent Change: +0.01...
Avidity Biosciences Insider Sold Shares Worth $980,760, According to a Recent SEC Filing
Avidity Biosciences Insider Sold Shares Worth $980,760, According to a Recent SEC Filing
Mar 15, 2024
04:16 PM EDT, 03/15/2024 (MT Newswires) -- Michael F MacLean, Chief Financial Officer, on March 13, 2024, sold 40,000 shares in Avidity Biosciences ( RNA ) for $980,760. Following the Form 4 filing with the SEC, MacLean has control over a total of 44,093 shares of the company, with 44,093 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1599901/000159990124000044/xslF345X03/wk-form4_1710533514.xml ...
High Tide Edges Down After Hours as the Cannabis Retailer Nearly Breaks Even in its Fiscal First Quarter
High Tide Edges Down After Hours as the Cannabis Retailer Nearly Breaks Even in its Fiscal First Quarter
Mar 15, 2024
04:18 PM EDT, 03/15/2024 (MT Newswires) -- High Tide (HITI.V, HITI) edged down in after-hours Nasdaq trading after the company on Friday said its fiscal first-quarter loss narrowed on sales gains. The cannabis retailer posted a loss of C$5,000, or nil per share, in the quarter ended Jan.31, compared with a loss of C$3.92 million, or C$0.05, in the year-prior...
Hims & Hers Health Insider Sold Shares Worth $965,016, According to a Recent SEC Filing
Hims & Hers Health Insider Sold Shares Worth $965,016, According to a Recent SEC Filing
Mar 15, 2024
04:15 PM EDT, 03/15/2024 (MT Newswires) -- Soleil Boughton, Chief Legal Officer, on March 13, 2024, sold 63,621 shares in Hims & Hers Health ( HIMS ) for $965,016. Following the Form 4 filing with the SEC, Boughton has control over a total of 154,345 shares of the company, with 154,345 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1773751/000177375124000059/xslF345X03/wk-form4_1710533549.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved